GB/T 16886.11-1997
Replaced
T/CNDIA 3-2025
Active
Group standards
T/CNDIA 3-2025 Clinical application guidelines of PRP for the treatment of femoral head necrosis
T/CNDIA 3-2025 Clinical application guidelines of PRP for the treatment of femoral head necrosis
Price:
$ 20.00
Basic Information
Standard Code:
T/CNDIA 3-2025
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Biological products and blood products
ICS Name:
Integrated medical equipment
Publish Date:
2025-10-30
Implement Date:
2025-11-10
Scope
This document specifies the clinical classification, symptoms, screening, indications and contraindications, institutional and personnel requirements, treatment process, follow-up, and adverse reaction monitoring of platelet-rich plasma (PRP) therapy for femoral head necrosis. This document is applicable to orthopedics and arthroscopic surgery departments in general hospitals for the treatment of patients with femoral head necrosis using PRP therapy. This document specifies the clinical classification, symptoms, screening, indications and contraindications, institutional and personnel requirements, treatment process, follow-up, and adverse reaction monitoring of PRP therapy for femoral head necrosis.
Development Information
Related Standards
GB/T 16886.3-1997
Replaced
GB/T 16886.3-1997 Biological evaluation of medical devices—Part 3:Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.6-1997
Replaced
GB/T 16886.6-1997 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
GB/T 16886.1-2001
Replaced
GB/T 16886.1-2001 Biological evaluation of medical devices—Part 1:Evaluation and testing
GB/T 16886.13-2001
Replaced
GB/T 16886.13-2001 Biological evaluation of medical devices—Part 13:Identification and quantification of degradation products from polymeric medical devices
GB/T 16886.7-2001
Replaced